Baseline characteristics and drug treatment during the study.
cancer, lung disease, diabetes
LUNG DISEASE, HEART DISEASE, CANCER, LUNG DISEASES, HYPERTENSION, DIABETES
Among the 387 study participants, 290 (74.9%) had at least 2 pre-existing comorbidities associated with increased risk for severe COVID-19, including hypertension, diabetes, heart disease, lung diseases, and cancer, while 97 participants (25.1%) had no identifiable risk factors at study entry. A pre-existing lung disease was present in 84 of 387 patients (21.7%). The incidence of various risk factors (RF) was similar in the two treatment groups (